Epstein, M, Gordon, W, Weinberger, M, Lewin, AJ, et al: Characterization of the Antiproteinuric Effect of Eplerenone in Patients with Type 2 Diabetes Mellitus, :
Gaudiani, L, Lewin, AJ, Meneghini, L, et al: Efficacy and Safety of Ezetimibe Coadministered With Simvastatin versus Simvastatin Alone in Thiazolidinedione-Treated Patients With Type 2 Diabetes Mellitus, :
Epstein, M, Weinberger, M, Bueno-Gomez, J, Lewin, AJ, et al: Eplerenone Dose as a Determinant of Hyperkalemia: A Comparison of 2 Clinical Trials., :
Feldman, T., Koren, M., Insull, W., Lewin, AJ, et al: Treatment of High Risk Patients With Ezetimibe Plus Simvastatin Coadministration Versus Simvastatin Alone to Attain National Cholesterol Education Program Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals., :
Epstein, M., Williams, GH, Lewin, AJ, et al: Characterization of the Antiproteinuric Effect of Eplerenone in Patients with Type 2 Diabetes Mellitus., :
Fox, J, Leight, K, Lewin, AJ, et. al: Treatment of Hypertension in Patients with Diabetes Mellitus: Initial Losartan/Hydrochlorothiazide Combination Compared Versus Ramipril Monotherapy. ., :
McKenney, J, Insull, Jr., W, Lewin, AJ, et al: LDL-Cholesterol Goal Attainment Among Patients With Diabetes Mellitus Treated With Ezetimibe Plus Simvastatin Coadministration Versus Simvastatin Alone., :
Gaudiani, L., Lewin, AJ, et al: Efficacy and Safety of Ezetimibe Coadministered with Simvastatin versus Simvastatin Alone in Thiazolidinedione-Treated Patients With Type 2 Diabetes Mellitus., :
Dr. Andrew Lewin
Dirección profesional:
National Research Institute 2010 Wilshire Blvd., Suite 302 Los Angeles, CA 90057, Osaka, Japón
|